Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
RG Advertising
KOREA E & EX

Sterilization Technology Kills Hospital Bedbugs

By HospiMedica International staff writers
Posted on 08 May 2013
Image: The AsepticSure portable sterilization system (Photo Courtesy of  Medizone International).
Image: The AsepticSure portable sterilization system (Photo Courtesy of Medizone International).
A new hospital sterilization system eradicates highly drug-resistant bacteria as well as a problem increasingly plaguing hospitals—bedbugs.

The AsepticSure sterilization system is a portable, affordable, easily operated system that is placed in the center of the room scheduled to be cleaned. The room vents and doors are then sealed with a cleanly removable adhesive tape product. The system is then turned on from outside of the room through a remote wireless computer interface, and the room is filled with a patented ozone-based gas formula with specific humidity and charge strength.

Following the charge period, the sterilization process is remotely turned off and a separate technology is employed that restores the atmosphere inside the room. The end result leaves the treated room sterile of pathogens with a sweet, fresh oxygen-charged atmosphere. Turnaround time for reuse of rooms up to 113 cubic meters in size is 80–90 minutes; this includes decontamination of carpets, drapes and medical equipment, all to the 6 log sterilization standard. The AsepticSure sterilization system is a product of Medizone International (San Francisco, CA, USA).

“The bedbugs, and particularly the eggs of bedbugs, are even harder to kill than the spores of the bacteria,” said Professor Dick Zoutman, MD, an infectious disease specialist at Queen’s University (Ontario, Canada), and chief medical officer of Medizone International. “Medizone is now working to adapt the system to kill bedbugs in a faster and more effective manner, both for hospitals and other settings as well.”

More than a third of pest-management companies treated bedbug infestations in hospitals in 2012, 6% more than the year before and more than twice as many as in 2010, according to a survey released today by the National Pest Management Association (Fairfax, VA, USA). While bedbugs do not transmit infections to humans, their bites can lead to secondary infections when victims scratch, opening themselves up to bacteria. This is especially problematic in hospitals, where there is a greater likelihood of infection with Methicillin-resistant Staphylococcus aureus (MRSA).

Related Links:

Medizone International
National Pest Management Association



Channels

Surgical Techniques

view channel

Raman Scattering Helps Evaluate Laser Ablation

Raman spectroscopy can be used to differentiate squamous cell carcinoma (SCC) from normal skin following treatment with high-powered lasers, according to a new study. Researchers at Florida Atlantic University (FAU; Boca Raton, USA) obtained 25 tissue samples from 11 patients undergoing Mohs micrographic surgery for... Read more

Women's Health

view channel

Nitrous Oxide for Labor Makes US Comeback

Long used for its anxiolytic properties during labor in European countries and Canada, nitrous oxide (N2O) use is resurging in the United States. While in countries such as Norway, New Zealand, Sweden, Australia, and England, usage rates of inhalational N2O during parturition reach 70%, it has only recently become an... Read more

Health IT

view channel
Image: Remote Intelligent Telehealth Assistant (RITA) (Photo courtesy of PR Newswire).

Telehealth Robot Launched to Increase Productivity of Doctors in Clinics and Hospitals

A robot uses high-definition monitors, high-speed components, and wireless communications, and serves as a telehealth media center to give doctors more flexibility in treating and assisting patients remotely.... Read more

Business

view channel

Pfizer to Buy Hospira to Bolster Hospital Products

Pfizer (New York, NY, USA) has entered into a definitive merger agreement with Hospira (Lake Forest, IL, USA), in a move designed to significantly enhance their global established pharmaceutical (GEP) business, for a total enterprise value of approximately USD 17 billion. The strategic complementary combination will... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.